HLA-DM Antibodies

Santa Cruz Biotechnology offers a broad range of HLA-DM monoclonal antibodies for immunology and cell biology research. HLA-DM Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLA-DM is a crucial component of the major histocompatibility complex (MHC) class II pathway, playing a significant role in the presentation of antigens to CD4+ T cells. By facilitating the exchange of peptides on MHC class II molecules, HLA-DM is essential for effective immune responses and the activation of adaptive immunity. Understanding HLA-DM function advances therapeutic strategies in autoimmune diseases and cancer immunotherapy. Research focusing on HLA-DM has revealed its importance in maintaining proper immune system function and regulation. Investigating HLA-DM interactions with other molecules provides valuable information about antigen presentation mechanisms. Exploring HLA-DM's role in various disease states helps identify potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of immune system regulation and disease mechanisms.